Floatz logo

Gnrh

Olfaction Disorders

Nelly Pitteloudprotein_peptidePhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Olfaction Disorders cohort.

Asset / SponsorPhaseRating
Gonadotropin-Releasing Hormone
Nelly Pitteloud
Phase 2/3B
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Nelly Pitteloud
Phase 2/3B
Ivacaftor
University of California, Los Angeles
D
ELEXACAFTOR
University of California, Los Angeles
D
Tezacaftor
University of California, Los Angeles
D
Cyr-064
University of Nebraska
Phase 1NR

Same molecule, other indications

Gnrh is also rated in:

cognitive disorderDormant
B
Indicative ·
57 / 100
View asset →
Down syndromeDormant
B
Indicative ·
57 / 100
View asset →
prostate disorderDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →